BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3394592)

  • 1. Update of the Wiskott-Aldrich syndrome. From a new case report.
    Martín Mateos MA; Muñoz-López F; Cruz M
    Allergol Immunopathol (Madr); 1988; 16(2):113-9. PubMed ID: 3394592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal immune responses in the ocular presentation of Wiskott-Aldrich syndrome.
    Guss RB; McCulley JP
    Ann Ophthalmol; 1982 Nov; 14(11):1058-60. PubMed ID: 7181336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Wiskott-Aldrich syndrome. Results of transfer factor therapy.
    Spitler LE; Levin AS; Stites DP; Fudenberg HH; Pirofsky B; August CS; Stiehm ER; Hitzig WH; Gatti RA
    J Clin Invest; 1972 Dec; 51(12):3216-24. PubMed ID: 4640955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Wiskott-Aldrich syndrome (literature review)].
    Shabalov NP
    Vopr Okhr Materin Det; 1975 Feb; 20(2):50-4. PubMed ID: 1094723
    [No Abstract]   [Full Text] [Related]  

  • 5. Phagocyte function and immunological findings in a Wiskott-Aldrich syndrome long-term survivor.
    Capsoni F; Acerbi L; Bonora G; Perletti L; Ongari AM; Vanoli M; Zanussi C
    J Clin Lab Immunol; 1986 Feb; 19(2):91-7. PubMed ID: 3754288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of the Wiskott-Aldrich syndrome by a graft of allogeneic bone marrow].
    Fischer A; Durandy A; Bordigoni P; Virelizier JL; Vilmer E; Arnaud-Battandier F; Lagrue A; Olive D; Griscelli C
    Arch Fr Pediatr; 1984 Nov; 41(9):611-6. PubMed ID: 6391414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wiskott-Aldrich syndrome complicated by an atypical lymphoproliferative disorder: a case report.
    Ma YC; Shyur SD; Ho TY; Huang LH; Wu JY; Liang DC; Chien YH
    J Microbiol Immunol Infect; 2005 Aug; 38(4):289-92. PubMed ID: 16118678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wiskott Aldrich syndrome: a treatable immune disorder. A review.
    Millikan LE
    Mo Med; 1973 Nov; 70(11):764-7 passim. PubMed ID: 4591682
    [No Abstract]   [Full Text] [Related]  

  • 9. A sporadic case of Wiskott-Aldrich syndrome.
    Vega M; Fernández M; Villa-Elizaga I; Córdoba H
    Allergol Immunopathol (Madr); 1990; 18(6):335-8. PubMed ID: 2088104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Wiskott-Aldrich syndrome: description of a clinical case].
    De Bernardi A; Chessa Ricotti G; Galli L; Funis M
    Pediatr Med Chir; 1990; 12(6):691-3. PubMed ID: 2093894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.
    Altman LC; Snyderman R; Blaese RM
    J Clin Invest; 1974 Aug; 54(2):486-93. PubMed ID: 4136226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercatabolism of IgG, IgA, IgM, and albumin in the Wiskott-Aldrich syndrome. A unique disorder of serum protein metabolism.
    Blaese RM; Strober W; Levy AL; Waldmann TA
    J Clin Invest; 1971 Nov; 50(11):2331-8. PubMed ID: 5096517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eczema in primary immune-deficiencies. Clues to the pathogenesis of atopic dermatitis with special reference to the Wiskott-Aldrich syndrome.
    Saurat JH
    Acta Derm Venereol Suppl (Stockh); 1985; 114():125-8. PubMed ID: 3890446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Congenital deficiency of humoral and cellular immunity].
    Vuković I; Korać D; Stojimirović E; Dinić B
    Bilt Hematol Transfuz; 1977; 5(3-4):47-57. PubMed ID: 307954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable mixed chimerism after hematopoietic stem cell transplantation in Wiskott-Aldrich syndrome.
    Doğu F; Kurtuluş-Ulküer M; Bilge Y; Bozdoğan G; Ulküer U; Malhatun E; Ikincioğullari A; Babacan E
    Pediatr Transplant; 2006 May; 10(3):395-9. PubMed ID: 16677369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Wiskott-Aldrich syndrome].
    Erttmann R; Thöne I; Landbeck G
    Monatsschr Kinderheilkd; 1983 Aug; 131(8):524-7. PubMed ID: 6605477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Wiskott-Aldrich syndrome. Recent information apropos of 4 cases].
    Griscelli C; Phan-Huu-Trung ; Herzog C; Mozziconacci P
    Nouv Rev Fr Hematol; 1973; 13(4):554-68. PubMed ID: 4271105
    [No Abstract]   [Full Text] [Related]  

  • 18. The Wiskott-Aldrich syndrome.
    Ormerod AD
    Int J Dermatol; 1985 Mar; 24(2):77-81. PubMed ID: 3886570
    [No Abstract]   [Full Text] [Related]  

  • 19. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
    Schut BJ; Dooren LJ; Uittenbogaart CH; Schellekens PT; Eijsvoogel VP
    Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Wiscott-Aldrich syndrome. Description of a case].
    Brai M; Balsamo V; Mogavero S; Romano N; Lagrutta A
    G Batteriol Virol Immunol; 1975; 68(1-6):130-9. PubMed ID: 1081964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.